Delivery Order SPE2DB22D2206-SPE2DB25FGF92

Award Date 3/24/25
Potential Completion Date 3/25/25
Potential Value $5.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,058.59 Firm Fixed Price delivery order is for the supply of 4567570471 - Progesterone 200 mg Capsule 100s. The contract has an ultimate completion date of March 14, 2025. This award is associated with AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,019.74 Delivery Order contract is for the supply of 4,567,600 units of Progesterone 200 mg capsules. The contract has a firm fixed price pricing type and an ultimate completion date of March 18, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,359.89 firm fixed-price delivery order is for the supply of 4,568,236,190 units of a 200 mg progesterone capsule product. The contract has an ultimate completion date of May 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with...
This federal contract award, valued at $18,557.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567752016 - Progesterone 200 mg Capsule 100s. This appears to be a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 1, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,704.77 firm fixed-price delivery order contract is for the supply of 100-count packages of 200mg progesterone capsules. The contract has an ultimate completion date of June 17, 2025 and is not set aside for any specific business type. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,486.08, is for the delivery of 4567707089 Progesterone 200 mg Capsules in 100-count bottles. The contract is a firm fixed-price delivery order with a completion date of March 27, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award, valued at $20,044.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,567,916,240 units of Progesterone 200 mg capsules, with an ultimate completion date of April 16, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,456.09, is a delivery order for the supply of 4567726860 - Progesterone 100 mg Capsule 100s. The contract has an ultimate completion date of March 31, 2025 and uses a firm fixed price pricing type. This contract award is associated with AmerisourceBergen's larger Indefinite Delivery Contract...
This federal contract award, valued at $12,351.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567774636 - Progesterone 200 mg Capsule 30s, with an ultimate completion date of April 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, worth $2,723.73, is a Delivery Order contract for the supply of 4566676034 - Progesterone 200 mg Capsule 100s. The contract has a period of performance through December 11, 2024 and is a Firm Fixed Price contract. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FGF92
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) for the supply of 4567678608 - Progesterone 200 mg Capsule 100s. The $5,338.14 Firm Fixed Price Delivery Order contract has a completion date of March 25, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This award was not designated with a set-aside.

Generated 6/29/25, 12:48 AM